Momenta: The Perfect Massachusetts Success Story

Momenta Pharmaceuticals has discovered that reining in the cost of health care can be hugely profitable. The company’s generic version of the anti-blood-clotting drug Lovenox — priced about 30 percent cheaper than the brand drug made by French pharmaceutical giant Sanofi SA — helped boost Momenta’s revenues by 142 percent to $283 million last year, while profits zoomed 383 percent to $180 million.
Boston Globe